MiRNA Sequencing And Assay Market Is Projected To Reach Approximately USD 597.8 Million By 2028: Grand View Research Inc.

 miRNA Sequencing And Assay Market Growth & Trends 

The global miRNA sequencing and assay market size is expected to reach USD 597.8 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.0% from 2021 to 2028. Prominent players, such as Illumina, PerkinElmer, Qiagen, and others offer advanced miRNA sequencing products for multiple clinical applications. Moreover, these companies have collaborated with research institutes to expand the application of miRNA sequencing and assay in research studies.

The market holds a significant growth potential owing to the increasing application of miRNA sequencing and assay in the healthcare industry. For instance, several research studies demonstrate that miRNAs can be used as efficient biomarkers in the diagnosis and prognosis of cancer (breast, ovarian, cervical, and others), cardiovascular diseases, sepsis, and nervous system disorders. Therefore, miRNA sequence analysis is increasingly employed to analyze gene regulation in clinical disorders.

As plasma from COVID-19 recovered patients is rich in antiviral miRNAs and antibodies, it has been employed to treat SARS-CoV-2 infected patients. This has led to an increase in research studies that focus on the sequence analysis of miRNAs (microRNA) from the patient as well as the virus.

Request a free sample copy or view report summary: miRNA Sequencing And Assay Market Report

miRNA Sequencing And Assay Market Report Highlights

• The product segment dominated the market and accounted for the largest revenue share in 2020. The commercial presence of multiple players that offer extensive kits, consumables, and instruments for specialized applications contribute to segment growth
• Small and mid-sized research entities face financial limitations to install sequencing equipment owing to their high cost. Therefore, these organizations approach service providers. This is expected to drive the services segment with the fastest CAGR over the forecast period
• Sequencing by synthesis holds a major share of the technology segment owing to its high sensitivity, fast turnaround time, and high throughput
• Additionally, this technology is playing important role in the detection of mutations in tumor tissue which helps to develop targeted and personalized therapies
• The sequencing workflow segment held the largest revenue share in 2020 and is expected to witness the fastest CAGR during the forecast period as it is the most important and crucial step of the workflow
• The cancer application segment generated the largest revenue share in 2020 owing to ongoing extensive research in cancer using miRNA as a biomarker to study diagnosis and prognosis of cancer and to develop novel therapies
• Furthermore, an increase in the number of cancer patients globally drives segment growth
• Research and academic institutions are one of the major revenue generators of the market as miRNA sequencing and assay techniques and associated products are being widely used in various research studies conducted by research and academic institutes
• In Asia Pacific, the market is anticipated to register a lucrative growth rate throughout the forecast owing to the presence of a huge target population, growing establishment of healthcare, and high unmet clinical needs

Access Press Release@ https://www.grandviewresearch.com/press-release/global-mirna-sequencing-assay-market

miRNA Sequencing And Assay Market Segmentation

Grand View Research has segmented the global miRNA sequencing and assay market on the basis of product & service, technology, workflow, application, end-use, and region:

miRNA Sequencing And Assay Product & Service Outlook (Revenue, USD Million, 2017 - 2028)

• Products
  • Library Preparation Kits
  • Sequencing Consumables
  • Instruments
• Services

miRNA Sequencing And Assay Technology Outlook (Revenue, USD Million, 2017 - 2028)

• Sequencing (Seq.) By Synthesis
• By Oligonucleotide Ligation and Detection (SOLiD)
• Nanopore Seq.
• Sanger Seq.
• Single Molecule Real-time (SMRT) Seq.

miRNA Sequencing And Assay Workflow Outlook (Revenue, USD Million, 2017 - 2028)

• Library Preparation
• Sequencing
• Data Analysis & Storage

miRNA Sequencing And Assay Application Outlook (Revenue, USD Million, 2017 - 2028)

• Cancer
• Polyglutamine Diseases
• Autoimmune Disease
• Schizophrenia
• Others

miRNA Sequencing And Assay End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Pharmaceutical & Biotechnology Industry
• Research and Academic Institutes
• Contract Research Organizations

miRNA Sequencing And Assay Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • UK.
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Market Players of miRNA Sequencing And Assay Market

• Thermo Fisher Scientific, Inc
• Illumina, Inc.
• QIAGEN
• PerkinElmer, Inc.
• Abcam plc
• New England Biolabs
• Takara Bio Inc.
• Lexogen GmbH
• Norgen Biotek Corp
• Maravai LifeSciences
• HTG Molecular Diagnostics, Inc.
• Meridian Bioscience, Inc.
• System Biosciences, LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.